Naoki Toma Selected Research

Naoki Toma Research Topics

Disease

9	Aneurysm (Aneurysms) 01/2020 - 01/2003
5	Carotid Stenosis (Carotid Artery Stenosis) 12/2021 - 12/2014
4	Pathologic Constriction (Stenosis) 12/2021 - 01/2003
4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2021 - 08/2017
4	Intracranial Aneurysm (Cerebral Aneurysm) 01/2020 - 01/2005
3	Thrombosis (Thrombus) 10/2022 - 01/2003
3	Wounds and Injuries (Trauma) 10/2021 - 01/2015
3	Embolism (Embolus) 01/2019 - 01/2003
2	Atherosclerosis 12/2021 - 01/2014
2	Hydrocephalus (Hydrocephaly) 10/2021 - 08/2017
2	Rupture 04/2018 - 09/2005
2	Fistula 01/2018 - 07/2013
2	Hyperplasia 02/2015 - 01/2015
2	Inflammation (Inflammations) 01/2015 - 01/2014
1	Ischemic Stroke 10/2022
1	Brain Injuries (Brain Injury) 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Cerebral Infarction 01/2019
1	Aortic Dissection 04/2018
1	Dyslipidemias (Dyslipidemia) 08/2017
1	Hypertriglyceridemia 08/2017
1	Hypertension (High Blood Pressure) 01/2015
1	Hypotension (Low Blood Pressure) 05/2013
1	Stroke (Strokes) 11/2011
1	Carotid Artery Diseases 11/2011
1	No-Reflow Phenomenon 10/2010
1	Neurologic Manifestations (Neurological Manifestations) 09/2008
1	Hypovolemia 10/2007
1	Anemia 10/2007
1	Neointima 01/2003

Drug/Important Bio-Agent (IBA)

6	TenascinIBA 01/2019 - 10/2005
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2017
4	PlatinumIBA 04/2016 - 01/2005
3	Triglycerides (Triacylglycerol)IBA 12/2021 - 08/2017
3	LDL CholesterolIBA 07/2021 - 12/2014
3	oxidized low density lipoproteinIBA 07/2021 - 12/2014
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 07/2021 - 01/2015
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019 - 08/2017
2	Cilostazol (Pletal)FDA LinkGeneric 01/2019 - 08/2017
2	Pancreatic Elastase (Elastase)IBA 04/2016 - 01/2009
2	Phenobarbital (Luminal)FDA Link 04/2016 - 01/2003
2	gellan sulfateIBA 04/2016 - 10/2014
2	C-Reactive ProteinIBA 01/2015 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 01/2014
2	SolutionsIBA 10/2014 - 10/2010
1	6-chloropenicillanic acid S-sulfoxideIBA 12/2021
1	LipidsIBA 12/2021
1	OsteopontinIBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 07/2021
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	PeriostinIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 04/2018
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2016
1	CholesterolIBA 02/2015
1	Angiotensin II Type 1 Receptor BlockersIBA 02/2015
1	Valsartan (Vals)FDA Link 01/2015
1	Angiotensin Receptor AntagonistsIBA 01/2015
1	von Willebrand FactorIBA 01/2015
1	Antihypertensive Agents (Antihypertensives)IBA 01/2015
1	AntigensIBA 01/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2014
1	AdiponectinIBA 01/2014
1	PTX3 proteinIBA 01/2014
1	CytokinesIBA 01/2014
1	Ethanol (Ethyl Alcohol)IBA 07/2013
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2010
1	Dihydrotachysterol (AT 10)IBA 01/2009
1	Contrast MediaIBA 08/2008
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2005
1	Heparin (Liquaemin)FDA LinkGeneric 01/2005
1	CollagenIBA 01/2003

Therapy/Procedure

11	Stents 10/2022 - 01/2003
3	Catheters 10/2022 - 02/2015
3	Carotid Endarterectomy 07/2021 - 11/2011
1	Thrombectomy 10/2022
1	Surgical Instruments (Clip) 01/2018
1	Endarterectomy (Thromboendarterectomy) 08/2017
1	Oral Administration 02/2015
1	Injections 05/2013
1	Embolic Protection Devices 10/2010
1	Blood Transfusion (Blood Transfusions) 10/2007